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There is little information on venous patency after pacing leads are inserted in veins during
pacemaker or implantable cardioverter deﬁbrillator (ICD) implantation. Herein we present a
report on venous patency during the immediate postoperative period after permanent
pacemaker or ICD implantation.
Subjects and Methods: Twenty-ﬁve patients underwent a permanent pacemaker or ICD
implantation by venous puncture method, and venography was performed 1 week later. We
assessed the pacemaker-implantation side, approach used, implanted device, number of
implanted leads, and clinical symptoms.
Results: Narrowing of the vein was found in 14 patients (56%), including 7 patients (28%)
with occlusion. Stenosis and occlusion were seen more in patients with left-sided implantation
than those with right-sided implantation (71% vs. 25%, P < 0:05). ICD implantation was
more frequently associated with venous stenosis or occlusion than pacemaker implantation
(65% vs. 37.5%, P < 0:05). The approach used and the number of leads implanted did not
correlate with venous stenosis or occlusion. Six of the 7 patients who developed complete
occlusion showed clinical symptoms.
Conclusion: Thrombus formation after pacemaker implantation can occur in the acute stage
within 1 week. The incidence of venous stenosis or thrombus formation was higher with left-
sided implantation and ICD.
(J Arrhythmia 2010; 26: 30–37)
Key words: Pacemaker, Implantable cardioverter deﬁbrillator, Venography
Introduction
Currently, implantable cardioverter deﬁbrillators
(ICDs) are widely used to prevent sudden cardiac
death due to cardiac arrest, and permanent pace-
makers are usually implanted for bradycardia-related
disorders.
To ensure the safety of pacemaker implantation,
attempts should be made to prevent the development
of complications, such as pneumothorax, by per-
forming preoperative venography. In addition, we
can conﬁrm the abnormal location or course of a
blood vessel while performing ICD insertion maneu-
vers.1) Even if preoperative venography conﬁrms the
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absence of vein occlusion or stenosis, we occasion-
ally experience cases with long-term venous occlu-
sion or stenosis due to permanent pacemaker or
ICD implantation.2–6) However, it has not yet been
clariﬁed which factors are associated with stenosis or
occlusion of the vein containing the pacemaker
leads. There is little information about post-implan-
tation condition of veins in patients after permanent
pacemaker or ICD implantation.7,8) Therefore, we
examined venous patency during the immediate
postoperative period after permanent pacemaker or
ICD implantation in patients who were implanted
with a device for the ﬁrst time.
Subjects and Method
We investigated 25 patients who underwent
permanent pacemaker or ICD implantation at Toho
University Ohashi Medical Center for treatment of
symptomatic bradycardia or as a preventive measure
against sudden cardiac death due to cardiac arrest.
There were 18 males and 7 females, with an average
age of 65 years. They included 17 patients with ICD
implantation and 8 patients with pacemaker implan-
tation. All patients underwent surgery using the
venous puncture method. The supraclavicular ap-
proach technique involves puncture of the subclavian
vein at the supraclavicular fossa, and the subclavic-
ular approach technique involves puncture of the
subclavian vein inferior to the midpoint of the
clavicle (Figure 1).
To assess the presence of a venous stenosis or
occlusion caused by thrombus formation, venogra-
phy was performed 1 week later through a peripheral
vein in the arm on the device-implanted side using
20ml of iopamil as a contrast medium. We explained
the venography procedure to 35 consecutive patients
but 10 of the patients refused contrast medium
administration. Twenty-ﬁve of the 35 patients agreed
to undergo the venography. Therefore this study did
not include consecutive patients. All enrolled pa-
tients provided informed consent for the procedures.
We assessed sex, age, underlying diseases, lead di-
ameter, the pacemaker-implanted side (left or right),
the approach (supraclavicular or subclavicular), the
implanted device (pacemaker or ICD), the number of
implanted leads, and the patient’s clinical symptoms.
The implanted devices were as follows: KDR701,
KDR703 and KSR701 (Kappa700) permanent pace-
makers, and 7229CX (gen) and 7273 (gen) ICDs
(Medtronic Inc.); 5332, 5338, and 2405 MS perma-
nent pacemakers (St. Jude Medical), and 1381 and
1480 permanent pacemakers (Guidant). All of the
lead materials were made of silicon.
A serum creatinine value of > 2:0mg/dl was
considered a contraindication for the use of contrast
material because such a value is suggestive of renal
dysfunction. However, no patient in this study had a
serum creatinine level of > 2:0mg/dl.
There was a diﬀerence in the lead run conﬁg-
uration between the supraclavicular and subclavicu-
lar approaches (Figure 1).
Figure 1 Diﬀerences in lead run conﬁguration between the supraclavicular and subclavicular approaches
Left: supraclavicular approach, Right: subclavicular approach
Venous puncture was performed at the site indicated with an arrow.
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There were no patients with persistent or parox-
ysmal atrial ﬁbrillation. All of the patients with sick
sinus syndrome were type II.
Lesions having a reduction in diameter of greater
than 75% were deﬁned as ‘‘stenoses’’, and lesions
with complete disruption as ‘‘occlusions’’.
Statistical analyses were performed using the chi-
square test with clinical manifestation as the param-
eter. A P value < 0.05 was considered clinically
signiﬁcant.
Results
The analysis data of the 25 patients in whom we
obtained results are shown in Tables 1 and 2.
The pacemakers and ICDs were implanted from
the left side of the chest in 17 patients, and from the
right side in 8 patients. Needle puncture to insert the
pacing leads was performed using the supraclavic-
ular approach in 14 patients and the subclavicular
approach in 11 patients. A single lead was implanted
in 8 patients, and 2 leads for atrial and ventricular
pacing in 17 patients. The details are outlined in
Table 3.
The details of the 17 patients in whom needle
puncture was performed on the left side are
presented in Figure 2, while those of the 8 patients
in whom the puncture was performed from the right
side are shown in Figure 3.
Narrowing of the vein far from the puncture site
was found in 14 patients (54%) (Table 4). The venous
stenosis image is shown in Figure 4. This patient was
an 82-year-old male, with idiopathic ventricular
tachycardia. He was implanted a 2-lead ICD using
the left subclavicular approach. A venous stenosis
developed far from the puncture site 1 week after
implantation. A complete occlusion occurred in 7
patients (28%); in ﬁve of these patients, collateral
circulation had developed. Patients with a left-sided
implantation had more stenosis or occlusion than
those with a right-sided implantation (71% vs. 25%,
P < 0:05). ICD implantation was more closely
Table 1 Characteristics and parameters
number sex age underlying disease Type of device Number of lead lead diameter (F) insertion site puncture site
1 M 82 VT ICD (DDD) 2 7, 9 L I
2 M 62 VT ICD (DDD) 2 9, 9 L S
3 F 57 AVB PM (DDD) 2 8, 8 L S
4 M 90 AVB PM (DDD) 2 7, 7 R S
5 M 51 SSS PM (DDD) 2 8, 8 R S
6 F 82 AVB PM (DDD) 2 8, 8 R S
7 M 71 Brugada synd. ICD (VVI) 1 11 L S
8 M 69 VT ICD (DDD) 2 9, 11 L I
9 M 80 AVB PM (DDD) 2 8, 8 R S
10 M 66 VF ICD (DDD) 2 9, 11 L I
11 M 38 AVB PM (DDD) 2 8, 8 L S
12 M 74 VF ICD (DDD) 2 9, 11 L I
13 M 75 VT ICD (VVI) 1 11 R I
14 M 68 VT ICD (DDD) 2 9, 9 L S
15 M 32 VT ICD (DDD) 2 9, 9 L I
16 M 42 VF ICD (DDD) 2 7, 9 L S
17 F 62 VT, ICD (VVI) 1 11 L I
18 F 64 SSS PM (DDD) 2 9, 9 R S
19 M 70 VT ICD (VVI) 1 9 L I
20 F 69 VF ICD (DDD) 2 9, 9 L S
21 F 68 Brugada synd. ICD (VVI) 1 9 R I
22 M 57 VT ICD (VVI) 1 9 L S
23 F 69 AVB PM (DDD) 2 8, 8 R S
24 M 59 Brugada synd. ICD (VVI) 1 9 L I
25 M 62 VF ICD (VVI) 1 9 L I
VT: Ventricular tachycardia, AVB: Atrioventricular block, SSS: Sick sinus syndrome, VF: Ventricular ﬁbrillation, ICD: Implantable
cardioverter deﬁbrillator, PM: Pacemaker, L: Left, R: Right, I: subclavicular approach, S: supraclavicular approach
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associated to venous stenosis or occlusion than was
pacemaker implantation (65% vs. 37.5%, P < 0:05).
The approach used and the number of leads
implanted did not correlate with venous stenosis
or occlusion. Of the 7 patients who developed a
complete occlusion at the central site of the puncture
in the vein, 6 showed clinical symptoms such as pain
in the arm. One patient in whom collateral circu-
lation had eﬀectively developed did not complain of
any occlusion-related symptoms.
All 7 patients with occlusion were implanted with
ICDs, and they consisted of 41% of the 17 cases with
ICD implantation. There was no signiﬁcant correla-
tion between the number of leads used and venous
occlusion. However, occlusions appeared in patients
who were implanted with a 9F or larger lead.
Occlusions were more frequent in the left-side
implantation group (86%), and in the subclavicular
approach group (86%).
Discussion
Short-term follow-up venography 1 week after
pacemaker implantation by venous puncture in order
to evaluate venous stenosis and occlusion has not
been reported previously. One week after the pace-
maker implantation, 7 patients (28%) had venous
occlusion. None of the patients had a venous stenosis
or occlusion at the puncture site, but it occurred at a
site central to the puncture in each instance.
Severe stenosis or complete occlusion of the
subclavian vein after pacemaker implantation has
been reported in 15–65% of cases.9–16) The incidence
Table 3 Distribution by puncture site, device, and lead
numbers in 25 patients
Insertion L/R 17/8
Puncture S/I 14/11
Device ICD/PM 17/8
Lead number 2/1 17/8
There were 17 patients in whom implantation had been
performed from the left side. A subclavicular approach was
used in 11 of these patients.
L: Left, R: Right, S: supraclavicular approach, I: subclavicular
approach, ICD: Implantable cardioverter deﬁbrillator, PM:
Pacemaker
Table 2 Clinical symptoms and venography 1 week after the implantation
number clinical manifestation Radiologic ﬁnding after one week
1 EUL complete obstruction, collateral (+)
2 nothing stenosis,
3 nothing stenosis
4 nothing not particular
5 nothing NP
6 nothing NP
7 nothing stenosis
8 SB, EUL complete obstruction, collateral (+)
9 nothing stenosis
10 SB stenosis
11 nothing stenosis
12 nothing complete obstruction, collateral (+)
13 SB, EUL complete obstruction, collateral (+)
14 nothing NP
15 nothing NP
16 nothing NP
17 SB, EUL complete obstruction, collateral (+)
18 nothing NP
19 SB NP
20 nothing NP
21 nothing NP
22 SB complete obstruction, collateral ()
23 nothing NP
24 EUL complete obstruction, collateral ()
25 nothing stenosis
EUL: Edema of upper limb, SB: Subcutaneous bleeding, NP: Not particular
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of acute venous thrombosis following pacemaker
implantation is reportedly low,17) while that of
chronic thrombotic occlusion of the subclavian vein
or inferior vena cava is 0.35–0.5%.18,19) In the
present study, venous stenosis or occlusion devel-
oped in 56% of patients within 1 week after
pacemaker implantation; the subclavicular approach
was performed in 32% of the patients, and the
supraclavicular approach, in 24%. There were no
signiﬁcant diﬀerences in venous stenosis among the
groups based on the approach used.
The reported risk factors for thrombosis leading to
stenosis include pacing mode, implantation site,
multiple leads, hormone therapy, prior history of
venous thrombosis, temporary pre-operative pace-
maker use, and infections.9–11,17,20,21) Some reports
have suggested an increased risk in venous throm-
bosis following implantation of a 2-lead DDD
pacemaker,20,22) whereas other reports have shown
no correlation of thrombosis with the number of
leads used.23,24) Therefore, the number of leads is
not considered to have a direct eﬀect. Our results
showed no signiﬁcant diﬀerences in risk among the
R : 8Insertion
I : 2S : 6Puncture
Device ICD 0 PM 6 ICD 2 PM 0
Lead number two : 6 single : 0 two : 0 single : 2
Symptom Y N Y N
0 6 1 1
L : 17Insertion
I : 9S : 8Puncture
Device ICD : 6 PM : 2 ICD : 9 PM : 0
Lead number two : 4 single : 2 two : 2 single : 0 two : 5 single : 4
symptom Y N Y N Y N Y N Y N
0 4 1 1 0 2 3 2 3 1
Figure 2 Distribution by puncture site,
device, and lead number, in 17 patients with
the device inserted from the left side
The subclavicular approach was used in 9 of
these patients. An ICD was implanted in all of
these patients.
Figure 3 Distribution by puncture site,
device, and lead number, in 8 patients in
whom the device was inserted from the
right side.
The supraclavicular approach was used in 6 of
these patients. A pacemaker was implanted in
all of these patients.
Table 4 Diﬀerences in puncture site, device, and lead
number, among 14 patients who developed thrombus.
Insertion L/R 12/2 P < 0.05
Puncture S/I 6/8 NS
Device ICD/PM 11/3 P < 0.05
Lead number 2/1 8/6 NS
Occlusion in 7 cases
Clinical symptom Yes/No 6/1 P < 0.01
There was a signiﬁcant increase in venous stenosis among the
left-sided pacemaker and implantable cardioverter deﬁbrillator
(ICD) implanted patients.
L: Left, R: Right, S: supraclavicular approach, I: subclavicular
approach, ICD: Implantable cardioverter deﬁbrillator, PM:
Pacemaker, NS: Not Signiﬁcant
J Arrhythmia Vol 26 No 1 2010
34
groups based on the number of leads. Our results
indicate that ICD-implanted patients tend to develop
a venous stenosis or occlusion more frequently than
pacemaker-implanted patients. This may be due to
the fact that the diameter of the ICD lead is larger
than that of the pacemaker’.
Venous stenosis occurred with a signiﬁcantly
greater frequency in the left-sided than right-sided
implantation. A higher occlusion rate with left-sided
implantation than with right-sided implantation has
been reported to be due to longer leads, which are
used for anatomical reasons, and increased contact
area within the vein.10) Our study also showed a
signiﬁcantly higher occlusion rate in patients with
left-sided implantation, and this may be attributed to
longer leads and increased vein contact area required
for left-sided implantation.
In addition, vessel lead tension diﬀers from right-
sided implantation in the anatomic perspective. With
left-sided implantation, there may be increased
irritation due to greater mechanical pressure between
the lead and vein wall. There are also anatomical
diﬀerences between the left and right brachiocephal-
ic veins; the left brachiocephalic vein is longer and
runs nearly horizontally. Therefore, while the right
brachiocephalic vein joins the superior vena cava in a
gentle arc, the left brachiocephalic vein joins the
superior vena cava at an obtuse angle, which causes
increased mechanical pressure in the latter case.
ICDs were implanted from the left side in more
patients, and this may have inﬂuenced the results.
Venous blood stagnation is also a factor in
thrombus formation. When blood ﬂow is almost
zero, plasma factor IX is activated by factor IX-
activating enzyme in red blood cell membranes, and
the intrinsic coagulation reaction is activated.25)
Because erythrocyte activation of factor IX and
blood-clotting reactions are promoted by individual
red blood cells with decreased shear ﬂow,25) veins
with pacemaker leads are more prone to thrombus
formation.
In this study, leads were inserted by venous
puncture in all patients. Lesions were located in the
vein at locations central to, and far removed from,
the puncture sites, suggesting that the surgical
technique did not substantially contribute to the
venous stenosis.
Although high rates of subclavian vein stenosis
after pacemaker implantation have been reported, the
incidence of clinical manifestations such as upper
limb edema is relatively low at about 5%.10,11,14,16,26)
In the present study, during the acute stage within 1
week after surgery, 6 of the 7 patients with a venous
occlusion developed upper limb edema and/or
subcutaneous bleeding; however, one patient had
no clinical manifestations. Furthermore, some pa-
tients with superior vena cava syndrome, have not
been reported to have any symptoms.5,27,28)
Based on the standard principle of performing
pacemaker implantation on the side of the non-
dominant arm, many medical facilities use the left-
sided approach. Thus, the risk for venous stenosis
Figure 4 Occlusion of the vein.
An 82-year-old, male, with idiopathic ventricular tachycardia. A 2-lead ICD was implanted from the left side using the subclavicular
approach. Venous stenosis occurred central to the puncture site, as shown in the venography performed 1 week after the implantation.
Left: venography, Right: digital subtraction angiography
Nakae T Venous patency in acute stage of pacemaker implantation
35
may be high in many patients with a pacemaker.
With aging of the population, numerous patients will
require long-term devices such as pacemakers. In
addition to the replacement of pacemaker batteries,
leads will also have to be replaced to increase device
longevity. In such patients, future reimplantation
may be necessary. Considering this future need for
reimplantation, a right-sided approach might be
preferable for implanting the initial device.
Hypercoagulability after pacemaker implantation
has been reported.12,29–32) Even among patients with
normal subclavian veins, elevated levels of throm-
bin-antithrombin complex (TAT) and D-dimer have
been reported,29,30) which can lead to other throm-
botic complications, including pulmonary embolism.
Indeed, high rates of thrombotic complications,
including pulmonary embolism, have been reported
after pacemaker implantation.23) Although some
thrombotic disorders cannot be identiﬁed by routine
hematologic data alone, because of potential throm-
botic complications after pacemaker implantation,
elevated TAT and D-dimer levels have been sug-
gested as predictive factors for subclavian vein
thrombosis.33) However, TAT and D-dimer levels
were not measured in the present study.
Our study did not evaluate the eﬀects of anti-
platelet or anticoagulant drugs on venous thrombo-
sis. However, given the hypercoagulable state and
the high incidence of subclavian vein thrombosis
that often occurs after pacemaker implantation, the
use of antiplatelet or anticoagulant drugs may be
recommended.
Limitations
This study did not evaluate the eﬀects of anti-
platelet or anticoagulant drugs on venous thrombo-
sis. In addition, we did not evaluate coagulation
abnormalities during the short postoperative period
or the level of TAT, D-dimer, and the thrombosis
originate factor.
Prior to venography, informed consent was ob-
tained from all patients included in this study.
However, many patients did not agree to undergo
venography because of the risk of side eﬀects and
the adverse eﬀects related to administering a contrast
agent. Therefore, the number of cases available for
evaluation was somewhat low.
The implantation side was chosen based on the
operator’s expertise. Therefore, we did not randomly
select the side, which may have caused the diﬀer-
ence between the left and right sides.
Venography was not performed before implanting
the pacemakers or ICDs. Therefore, a venous
stenosis might have been found before the operation
in some cases.
Multivariable analysis could not be performed
because the number of variable samples were small.
A further study with a larger sample size is
warranted. A long-term follow-up of our patient
series would also provide additional information.
Conclusion
Venous stenosis or occlusion developed in 56% of
the patients during the acute stage within 1 week
after pacemaker implantation. However, venous
stenosis or occlusion did not occur at the puncture
site, but developed at sites central to the puncture.
The incidence of venous stenosis or thrombus
formation was signiﬁcantly higher with left-sided
implantation and implantation of ICD. Even with
cases of venous occlusion with thrombus formation,
no clinical manifestations could be observed due to
the development of collateral blood circulation.
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